Clinical Trial Update: Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating transplantation of CRISPR-modified hematopoietic progenitor stem cells (CRISPR_SCD001) in patients with severe sickle c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• CRISPR_SCD001 (CRISPR-modified hematopoietic progenitor stem cells)

Snippet

Sponsor: Mark Walters, MD | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: RECRUITING